El Salvador vs South-East Asia (WHO region): Hypertension treatment coverage among adults aged 30-79 with
El Salvador
62.6%
in 2019
South-East Asia (WHO region)
31.8%
in 2019
El Salvador rank
12th
South-East Asia (WHO region) rank
9th
Hypertension treatment coverage among adults aged 30-79 with over time
- El Salvador
- South-East Asia (WHO region)
How they compare
El Salvador currently reports 62.6% against 31.8% in South-East Asia (WHO region), a difference of 30.8%.
That makes El Salvador's figure about 2.0 times South-East Asia (WHO region)'s.
Across all 30 years both countries report, El Salvador has been ahead every year.
El Salvador ranks 12th and South-East Asia (WHO region) ranks 9th of 193 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.4% | 12.0% | 25.4% | El Salvador |
| 2000s | 48.8% | 20.0% | 28.8% | El Salvador |
| 2010s | 59.8% | 28.5% | 31.3% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension treatment coverage among adults aged 30-79 with, El Salvador or South-East Asia (WHO region)?
- El Salvador, at 62.6% against 31.8% in South-East Asia (WHO region) as of 2019.
- What is the difference in hypertension treatment coverage among adults aged 30-79 with between El Salvador and South-East Asia (WHO region)?
- 30.8%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and South-East Asia (WHO region)?
- 30 years are reported by both, from 1990 to 2019.
- How do El Salvador and South-East Asia (WHO region) rank globally for hypertension treatment coverage among adults aged 30-79 with?
- El Salvador ranks 12th and South-East Asia (WHO region) ranks 9th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension treatment coverage among adults aged 30-79 with hypertension, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.